(QLTI) The 2023 Series Trust II - Ratings and Ratios

The 2023 ETF Series Trust II (NASDAQ:QLTI) is an actively managed exchange-traded fund (ETF) designed to invest primarily in non-U.S. equities identified by its adviser, Grantham, Mayo, Van Otterloo & Co. LLC (GMO), as high-quality securities. The fund may also allocate to the GMO U.S. Treasury Fund, a mutual fund managed by GMO, or to unaffiliated money market funds, and it can directly invest in instruments typically held by money market funds. As a non-diversified fund, it can concentrate its holdings in a limited number of securities, which may amplify both potential returns and risks. The funds investment strategy focuses on identifying companies with strong financial health, competitive advantages, and attractive valuations, leveraging GMOs global equity research capabilities.

From a technical perspective, QLTI is trading at $25.10, above its 20-day ($24.48) and 50-day ($23.88) simple moving averages (SMAs), while slightly above its 200-day SMA ($23.82). The Average True Range (ATR) of 0.44 indicates relatively low volatility. Over the next three months, if the funds price maintains its current trajectory above the 20-day SMA and breaches the $25.50 resistance level, it could signal further upside. However, if it falls below the 50-day SMA ($23.88), it may enter a consolidation phase.